Regulatory withdrawal of medicines marketed with uncertain benefits : the bevacizumab case study
MetadataShow full item record
Vitry , A , Nguyen , T , Entwistle , V & Roughead , E 2015 , ' Regulatory withdrawal of medicines marketed with uncertain benefits : the bevacizumab case study ' Journal of Pharmaceutical Policy and Practice , vol. 8 , 25 . DOI: 10.1186/s40545-015-0046-2
© 2015 Vitry et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.